Vapers Digest 12th April
Wednesday’s News at a glance:
What’s going on in Washington? (A collection featuring Dr. Gottleib) ~RESUMEN 2017 ABRIL SEMANA 1 ~ Liz Wager: How much of a conflict of interest is too much for a peer reviewer? ~ “There is never a situation where it is better to smoke than it is to vape.” Never? ~ GFN taking the debate on vaping on the road ~ Participants sought for e-cigarette stop-smoking trial ~ New laws restricting sale of e-liquids and e-cigarettes will ‘make vaping more expensive’ ~ What’s Your Company Policy on E-Cigarettes? ~ E-cigarettes are a cost-effective way to help smokers quit, HIQA claims
What’s going on in Washington?
Along with the graphic above, below is a collection featuring Trump nominee for the U.S. Food and Drug Administration, Dr. Scott Gottlieb
Después de estándares para los cigarrillos electrónicos, e-líquidos y emisiones, un nuevo documento define los compromisos de servicios en las tiendas. De acuerdo con Federación Interprofesional del vapeo en Francia (FIVAPE), actualmente Francia cuenta con 12.800 tiendas que para apoyar su crecimiento, los profesionales involucrados se han puesto de acuerdo sobre las mejores prácticas con respecto a los servicios que un consumidor tiene derecho a esperar.
BMJ Opinion, Liz Wager
One of the conundrums of peer review is that reviewers need to be knowledgeable about the research being reported but shouldn’t have conflicts of interest. The trouble is that the best-qualified people are often too closely connected to either the research or the authors.
— A Billion Lives (@ABillionLives) April 12, 2017
Simon Clark, Talking Liberties
Further to yesterday’s post Dick Puddlecote reports that the Independent British Vape Trade Association (IBVTA) has amended its code of conduct.
Coming to a Cinema near You – Reserve your tickets Now!
Paddy Costall, Nicotine Science and Policy
n March the GFN team organised a series of three dialogues in the UK to explore ‘How safe is vaping? Media coverage, dilemmas and solutions in work and social spaces’ These, each hosted by local partners, took place in Leicester, Liverpool and Glasgow.
The format was for a panel of leading thinkers and advocates to give short introductions, followed by a discussion involving the audience. Each event was designed to last for about 2 hours.
NZDoctor.co.nz. , University of Auckland
A clinical trial by the University of Auckland is calling for smokers to take part in their stop-smoking programme using nicotine patches and e-cigarettes.
NEW laws restricting the sales of e-liquids and e-cigarettes will “inevitably” push up the cost of vaping, a trade organisation has warned. Vaping devices are known for being cheaper than cigarettes and are designed as way to help smokers kick their habit.
Journal of Occupational and Environmental Medicine, NewsWise
As E-cigarettes continue to increase in popularity, employees are unclear on whether their employers have any company policy on “vaping”—or whether that policy is different for vaping versus tobacco smoking, reports a survey study in the April Journal of Occupational and Environmental Medicine.
E-cigarettes are a cost-effective way to help people quit smoking, a new report has found. HIQA carried out the first study in the EU to examine the cost effectiveness of e-cigarettes in quit attempts.
A look back at how things have moved on or otherwise…
Reignite E-Cig Growth With the New iQOS? – The Motley Fool
Philip Morris International probably won’t appease the anti-smoking crowd that seems just as interested in stamping out tobacco companies as they are about curtailing the use of cigarettes, but the company’s rollout of its new iQOS real tobacco electronic cigarette could revive the flagging sector.
On Wednesday, House appropriators will face a decision with major ramifications for efforts to combat smoking and protect public health. The Food and Drug Administration is poised to adopt rules that could cripple the e-cigarette industry, obstructing the availability of a safer alternative to cigarettes. The appropriators may be the last line of defense against wrong-headed action by the FDA.
Visit Nicotine Science & Policy for more News from around the World